期刊文献+

2型糖尿病患者血清CA19-9升高影响因素分析 被引量:7

Analysis on influencing factors for elevated serum CA19-9 in patients with type 2 diabetes
下载PDF
导出
摘要 目的探讨2型糖尿病患者血清中糖类抗原CA19-9升高的影响因素。方法入选460例2型糖尿病患者,按血清中CA19-9水平,分为CA19-9正常组(CA19-9≤37 U/ml)及CA19-9升高组(CA19-9>37 U/ml)。检测糖化血红蛋白(HbAlc)、空腹血糖(FPG)、总胆固醇(TC)、低密度脂蛋白-胆固醇(LDL-C)、甘油三酯(TG)、胰岛素样生长因子1(IGF-1)等。分析两组在性别、年龄、糖尿病病程、体质指数(BMI)等方面有无差异。对上述因素进行血清CA19-9升高相关因素逐步logsti回归分析。结果女性、HBA1c、TC、LDL-C均是2型糖尿病患者CA19-9升高的危险因素(P<0.05),而年龄、BMI、糖尿病病程、FPG、IGF-1、甘油三酯水平对2型糖尿病患者CA19-9升高的影响无统计学意义(P>0.05)。相关性分析显示CA19-9升高与HbAlc及性别相关(P值均<0.05)。结论 2型糖尿病患者CA19-9升高与HbAlc及性别相关。 Objective To study influence factors for elevation of serum CAl9-9 in patients with type 2 diabetes.Methods Four hundred and sixty patients with type 2 diabetes were divided into CA19-9 normal group(CAl9-9≤37 U/ml) and CA19-9 elevated group(CAl9-937 U/ml) according to the serum level of Ca 19-9.Glycosylated hemoglobin(HbAlc),fasting plasma glucose(FPG),total cholesterol(TC),lower density lipoprotein-cholesterol(LDL-C),triglyceride(TG) and insulin-like growth factor(IGF-1) were examined in all patients.The difference in gender,age,duration of diabetes,body mass index(BMI) etc was analyzed between these two groups.Step-wise logistics regression analysis was performed to compare above factors.Results For female patients with type 2 diabetes,HBA1c,TC and LDL-C were their risk factors for elevation of CA19-9(P0.05),and there were no statistical significance(P0.05) among age,duration of diabetes,BMI,and levels of FPG,and IGF-1 and triglyceride.The correlation analysis showed that the elevation of serum CA19-9 was related with HbAlc and gender(P0.05).Conclusion The elevation of serum CA19-9 is related with HbAlc and gender in patients with type 2 diabetes.
出处 《临床和实验医学杂志》 2012年第3期164-165,共2页 Journal of Clinical and Experimental Medicine
关键词 2型糖尿病 CA19-9 糖化血红蛋白 性别 Type 2 diabetes CAl9-9 Glycosylated hemoglobin Gender
  • 相关文献

参考文献12

二级参考文献61

  • 1王燕燕,王晓,赵明,汤沂.2型糖尿病患者左心室功能变化的临床研究[J].医学研究生学报,2006,19(3):247-249. 被引量:5
  • 2顾东风,Jiang He,吴锡桂,段秀芳,姚崇华,王家良,Kristi Reynolds,Chung-Shiuan Chen,Michael J.Klag,Paul K.Whelton.中国成年人主要死亡原因及其危险因素[J].中国慢性病预防与控制,2006,14(3):149-154. 被引量:75
  • 3徐婷,颜勤明,徐丽伟.2型糖尿病患者血清CA19-9浓度的变化及其与血糖的相关性[J].实用医学杂志,2007,23(5):676-677. 被引量:21
  • 4Locker GY, Hamiton S, Harris J, Jessup JM, Kemeny N, Macdonald JS, Somerfield MR, Hayes DF, Bast RC Jr. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer[J].J Clin Oncol, 2006, 24 : 5313 - 5327.
  • 5Murray MD, Burton FR, Di Bisceglie AM, Markedly elevated serum CA 19-9 levels in association with a benign biliary stricture due to primary sclerosing cholangitis[J]. J Clin Gastroenterol 2007, 41 : 115 - 117.
  • 6Mohan V, Premalatha G and Pitchumoni CS. Pancreatic diseases and diabetes. In: Textbook of diabetes. Eds: Pickup JC and Williams G. Third edition [J]. USA: Blackwell Publishing, 2003, 28 : 1 - 15.
  • 7Benhamou PY, Vuillez JP, Halimi S, Meffre G, Bachelot I. Influence of metabolic disturbances of diabetes mellitus on serum CA 19- 9 tumor marker [J].Diabete Metab 1991, 17 : 39 - 43.
  • 8Banfi G, Ardemagni A, Bravi S, Pacchioni M, Bonini P. Are diabetic metabolic compenstion and CA19.9 really correlated [J]. Int J Biol Markers 1996, 11:207- 210.
  • 9Uygur-Bayramicli O, Dabak R, Orbay E, Dolapcioglu C, Sargin M, Kilicoglu G, Guleryuzlu Y, Mayadagli A. Type 2 diabetes mellitus and CA 19 - 9 levels.
  • 10Inoue M,Iwasaki M,Otani M,et al.Diabetes mellitus and the risk of cancer results from a large-scale population-based cohort study in Japan.Arch Intern Med,2006,166:1871-1877.

共引文献2437

同被引文献49

引证文献7

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部